Liver Cancer Global Market Report 2025

Description

Liver cancer is a type of malignant disease that begins in the liver cells, primarily hepatocytes, and has the potential to spread to other organs. It is linked to risk factors such as chronic infections with hepatitis B and C, cirrhosis, excessive alcohol use, and non-alcoholic fatty liver disease (NAFLD). The disease is often diagnosed in its advanced stages, making early detection and treatment essential for improving survival rates.

The main forms of liver cancer include hepatoblastoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and fibrolamellar carcinoma. Hepatoblastoma is a rare form of liver cancer that typically affects young children and arises from immature liver cells. Liver cancer progresses through various stages, including the early, intermediate, and advanced stages. Treatment options include targeted therapy, radiation therapy, surgery, chemotherapy, and immunotherapy. The primary end users of these treatments are hospitals, specialty clinics, ambulatory surgical centers, and cancer research institutes.

The liver cancer market research report is one of a series of new reports from The Business Research Company that provides liver cancer market statistics, including the liver cancer industry global market size, regional shares, competitors with the liver cancer market share, detailed liver cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the liver cancer industry. This liver cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The liver cancer market size has grown rapidly in recent years. It will grow from $2.94 billion in 2024 to $3.37 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth during the historic period can be attributed to the increasing global incidence of liver cancer, the rising prevalence of hepatitis B and C infections, higher rates of non-alcoholic fatty liver disease, government initiatives encouraging early diagnosis, and growing awareness about liver health.

The liver cancer market size is expected to see rapid growth in the next few years. It will grow to $5.75 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth during the forecast period can be attributed to the expanding geriatric population, higher healthcare spending, increasing demand for minimally invasive treatments, a rise in specialty clinics, and the growth of medical tourism. Key trends during this period include advancements in diagnostic technologies, the development of targeted therapies, the introduction of combination therapies, technological innovations in surgical procedures, and progress in radiotherapy techniques.

The growing consumption of alcohol is expected to drive the expansion of the liver cancer market. Alcohol consumption, typically measured by its quantity and frequency, has been rising as it helps people relieve daily stress, fosters social interaction, and enhances relaxation, with its promotion in media and increased accessibility in various settings. However, excessive alcohol intake can lead to liver cirrhosis, inflammation, and DNA damage, which increases the risk of liver cancer by encouraging abnormal cell growth. For example, in March 2023, the National Drugs Library, an Ireland-based data collection organization, reported that the average alcohol consumption for individuals aged 15 and older increased to 10.2 liters of pure alcohol per capita in 2022, reflecting a 7.6% rise from 2021. This increase in alcohol consumption is contributing to the growth of the liver cancer market.

Leading companies in the liver cancer market are focusing on developing advanced therapy devices, specifically transcatheter arterial chemoembolization (TACE), to improve treatment precision, patient outcomes, and reduce side effects. TACE is a minimally invasive procedure that delivers chemotherapy directly to a liver tumor while blocking its blood supply to increase the treatment's effectiveness. For example, in November 2023, Terumo Corporation, a Japan-based medical technology company, launched two innovative therapy devices, Occlusafe and LifePearl, to assist in the management of liver cancer. These devices are designed to improve the treatment of hepatocellular carcinoma (HCC), the most common type of primary liver cancer in India, which sees over 20,000 new cases each year. Occlusafe is part of a cutting-edge therapy known as Balloon-TACE (B-TACE), which increases the precision and effectiveness of TACE by using a balloon to block blood flow during the procedure. LifePearl consists of polyethylene glycol (PEG) embolization microspheres, which can be loaded with chemotherapeutic agents.

In August 2023, TriSalus Life Sciences, a U.S.-based medical technology company focused on oncology, merged with MedTech Acquisition Corporation. This merger is intended to strengthen TriSalus Life Sciences' financial position and support the development of innovative treatments for liver and pancreatic tumors. MedTech Acquisition Corporation is a special purpose acquisition company (SPAC) that targets mergers with existing medical technology firms.

Major players in the liver cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Siemens Healthineers AG, Terumo Corporation, Eisai Co. Ltd., Qiagen N.V., Exelixis Inc., BeiGene Ltd., RayzeBio Inc., Innovent Biologics Inc., Celsion Corporation.

North America was the largest region in the liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liver cancer market consists of revenues earned by entities providing services such as early screening, palliative care, liver transplantation, personalized medicine, and radiofrequency ablation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cancer market also includes sales of diagnostic imaging equipment, biomarker tests, embolization devices, and supportive care medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Hepatoblastoma; Intrahepatic Cholangiocarcinoma; Hepatocellular Carcinoma; Fibrolamellar Carcinoma
2) By Stage Of Liver Cancer: Early Stage; Intermediate Stage; Advanced Stage
3) By Treatment: Targeted Therapy; Radiation Therapy; Surgery; Chemotherapy; Immunotherapy
4) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Cancer Research Institutes
Sub Segments:
1) By Hepatoblastoma: Epithelial Hepatoblastoma; Mixed Epithelial and Mesenchymal Hepatoblastoma
2) By Intrahepatic Cholangiocarcinoma: Mass-forming Cholangiocarcinoma; Periductal Infiltrating Cholangiocarcinoma; Intraductal Growing Cholangiocarcinoma
3) By Hepatocellular Carcinoma: Fibrolamellar Hepatocellular Carcinoma; Conventional Hepatocellular Carcinoma; Scirrhous Hepatocellular Carcinoma; Clear Cell Hepatocellular Carcinoma; Lymphoepithelioma-like Hepatocellular Carcinoma
4) By Fibrolamellar Carcinoma: Classic Fibrolamellar Carcinoma; Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34603

1. Executive Summary

2. Liver Cancer Market Characteristics

3. Liver Cancer Market Trends And Strategies

4. Liver Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Liver Cancer Growth Analysis And Strategic Analysis Framework

5.1. Global Liver Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Liver Cancer Market Growth Rate Analysis
5.4. Global Liver Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Liver Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Liver Cancer Total Addressable Market (TAM)

6. Liver Cancer Market Segmentation

6.1. Global Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatoblastoma
Intrahepatic Cholangiocarcinoma
Hepatocellular Carcinoma
Fibrolamellar Carcinoma
6.2. Global Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Stage
Intermediate Stage
Advanced Stage
6.3. Global Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Therapy
Radiation Therapy
Surgery
Chemotherapy
Immunotherapy
6.4. Global Liver Cancer Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
6.5. Global Liver Cancer Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Epithelial Hepatoblastoma
Mixed Epithelial and Mesenchymal Hepatoblastoma
6.6. Global Liver Cancer Market, Sub-Segmentation Of Intrahepatic Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass-forming Cholangiocarcinoma
Periductal Infiltrating Cholangiocarcinoma
Intraductal Growing Cholangiocarcinoma
6.7. Global Liver Cancer Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fibrolamellar Hepatocellular Carcinoma
Conventional Hepatocellular Carcinoma
Scirrhous Hepatocellular Carcinoma
Clear Cell Hepatocellular Carcinoma
Lymphoepithelioma-like Hepatocellular Carcinoma
6.8. Global Liver Cancer Market, Sub-Segmentation Of Fibrolamellar Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Classic Fibrolamellar Carcinoma
Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma

7. Liver Cancer Market Regional And Country Analysis

7.1. Global Liver Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Liver Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Cancer Market

8.1. Asia-Pacific Liver Cancer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Cancer Market

9.1. China Liver Cancer Market Overview
9.2. China Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Cancer Market

10.1. India Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Cancer Market

11.1. Japan Liver Cancer Market Overview
11.2. Japan Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Cancer Market

12.1. Australia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Cancer Market

13.1. Indonesia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Cancer Market

14.1. South Korea Liver Cancer Market Overview
14.2. South Korea Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Cancer Market

15.1. Western Europe Liver Cancer Market Overview
15.2. Western Europe Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Cancer Market

16.1. UK Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Cancer Market

17.1. Germany Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Cancer Market

18.1. France Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Cancer Market

19.1. Italy Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Cancer Market

20.1. Spain Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Cancer Market

21.1. Eastern Europe Liver Cancer Market Overview
21.2. Eastern Europe Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Cancer Market

22.1. Russia Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Cancer Market

23.1. North America Liver Cancer Market Overview
23.2. North America Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Cancer Market

24.1. USA Liver Cancer Market Overview
24.2. USA Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Cancer Market

25.1. Canada Liver Cancer Market Overview
25.2. Canada Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Cancer Market

26.1. South America Liver Cancer Market Overview
26.2. South America Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Cancer Market

27.1. Brazil Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Cancer Market

28.1. Middle East Liver Cancer Market Overview
28.2. Middle East Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Cancer Market

29.1. Africa Liver Cancer Market Overview
29.2. Africa Liver Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Liver Cancer Market, Segmentation By Stage Of Liver Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Liver Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Cancer Market Competitive Landscape And Company Profiles

30.1. Liver Cancer Market Competitive Landscape
30.2. Liver Cancer Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Liver Cancer Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. Thermo Fisher Scientific Inc.
31.4. AstraZeneca PLC
31.5. Abbott Laboratories
31.6. Novartis AG
31.7. Eli Lilly and Company
31.8. Siemens Healthineers AG
31.9. Terumo Corporation
31.10. Eisai Co. Ltd.
31.11. Qiagen N.V.
31.12. Exelixis Inc.
31.13. BeiGene Ltd.
31.14. RayzeBio Inc.
31.15. Innovent Biologics Inc.

32. Global Liver Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Cancer Market

34. Recent Developments In The Liver Cancer Market

35. Liver Cancer Market High Potential Countries, Segments and Strategies

35.1 Liver Cancer Market In 2029 - Countries Offering Most New Opportunities
35.2 Liver Cancer Market In 2029 - Segments Offering Most New Opportunities
35.3 Liver Cancer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer